Massachusetts Eye and Ear Infirmary

Quick facts

Marketed products

• Arificial Tear · Ophthalmology
  Artificial tears are lubricating eye drops that supplement or replace the eye's natural tear film to relieve dryness and irritation.
• Atropine 1% · Ophthalmology
  Atropine blocks muscarinic acetylcholine receptors to inhibit parasympathetic activity, causing pupil dilation and cycloplegia when applied topically to the eye.
• B+L Advanced Eye Relief Lubricant Drop · Ophthalmology
  This lubricating eye drop provides moisture and relief to dry eyes by forming a protective film on the ocular surface.
• Clear Care® · Ophthalmology
  Clear Care® is a hydrogen peroxide-based contact lens cleaning and disinfection system that uses catalytic breakdown to remove protein and lipid deposits while disinfecting lenses.
• Cyclosporine A 0.05%
• Loteprednol/tobramycin · Ophthalmology
  Loteprednol reduces ocular inflammation via glucocorticoid receptor activation, while tobramycin provides broad-spectrum bacterial coverage by inhibiting bacterial protein synthesis.
• OPTI-FREE® RepleniSH®
• ReNu MultiPlus® MultiPurpose Solution · Ophthalmology
  ReNu MultiPlus is a multipurpose contact lens solution that cleans, disinfects, and stores soft contact lenses through chemical disinfection and surfactant-based cleaning.
• Visine Dry Eye Relief eye drops · Ophthalmology
  Visine Dry Eye Relief lubricates and protects the ocular surface by providing artificial tears to supplement insufficient natural tear production.

Phase 1 pipeline

• Brimonidine 0.2%-0.5% timolol 0.5
• Brimonidine, pilocarpine
• Cultivation of Limbal epithelial cells into a graft
• Dorzolamide 2%-timolol 0.5%
• Doxycycline Injection [Doxy]

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Massachusetts Eye and Ear Infirmary portfolio CI brief
• Massachusetts Eye and Ear Infirmary pipeline updates RSS